AzTrials
AzTrials

StrokeNCT07882082

Analysis of Electroencephalogram (EEG) Changes in Subacute Stroke Patients

An observational study of Stroke and Electroencephalogram (EEG), run by Bundang CHA Hospital at 1 site in South Korea.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to examine how electroencephalogram (EEG) measures change over time in patients with stroke and to compare EEG measures according to the location of brain injury. Associations between EEG measures, function, and brain activity will also be analyzed. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Stroke, Electroencephalogram (EEG)
How many people
200 participants
Where
1 siteSouth Korea
Study dates
21 Apr 2021to 31 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult stroke patients (aged 20 years or older) recruited from the Department of Rehabilitation Medicine. Participants include patients in the subacute to chronic recovery phases. Eligibility requires a stable clinical condition suitable for serial Electroencephalogram (EEG) recordings and all required clinical assessments, and the provision of written informed consent. Patients deemed clinically unsuitable by the investigator will be excluded

Who may be able to join

  • Adult patients, male or female, aged 20 years or older.
  • Diagnosed with stroke (ischemic or hemorrhagic) and transferred to the Department of Rehabilitation Medicine
  • In a stable condition that permits Electroencephalogram (EEG) acquisition
  • The patient or their legally authorized representative has fully understood the details of this clinical study, voluntarily decided to participate, and provided written informed consent

Who cannot join

  • Any case determined by the investigator to be unsuitable for participation in the clinical study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

South Korea1 site, 1 recruiting
  • Bundang CHA Hospital

    Seongnam-si, Gyeonggi-do, 13496

    Yubin Kim, +82-31-780-6003, a240285@chamc.co.kr

    Recruiting

Other trials in South Korea

About this study

This study aims to examine how electroencephalogram (EEG) measures change over time in patients with stroke and to compare EEG measures according to the location of brain injury. Associations between EEG measures, function, and brain activity will also be analyzed.

Read the detailed description

This observational study will enroll 200 patients with stroke aged 20 years or older. Participants will undergo an initial EEG assessment and up to four follow-up assessments, with fNIRS measured alongside EEG. EEG measures will be compared by brain lesion location and analyzed in relation to functional assessments and brain activity. Follow-up data will be used to examine correlations between functional improvement and changes in EEG waveforms.

Keywords
Electroencephalogram (EEG), Functional Near-Infrared Spectroscopy (fNIRS)
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07882082
Study groupRoleWhat they receive
Stroke PatientsPatients with stroke aged 20 years or older who have been transferred to the Department of Rehabilitation Medicine and are able to undergo EEG assessment. Participants will undergo an initial EEG assessment and up to four follow-up assessments, with fNIRS measured alongside EEG.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EEG spectral power

    Spectral power across EEG frequency bands will be measured and compared by brain lesion location and over time. Associations with functional assessments and brain activity will also be analyzed.

    Measured: Baseline and up to 5 years

Secondary outcomes (1)
  1. Cerebral oxygenated hemoglobin concentration measured using fNIRS

    Cerebral oxygenated hemoglobin concentration will be measured using functional near-infrared spectroscopy (fNIRS) to assess brain activity.

    Measured: Baseline and up to 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2026
  2. Study start21 Apr 2021
  3. Primary completion31 Mar 2027 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07882082
Sponsor's protocol ID
2021-04-006
Status last verified
Oct 2026
First submitted
28 May 2026
Last updated
20 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Electroencephalogram (EEG), run by Bundang CHA Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yubin Kim (+82-31-780-6003, a240285@chamc.co.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EEG spectral power (time frame: Baseline and up to 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in